欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/5454/001
药品名称Enzalutamide Sandoz 40 mg film-coated tablets
活性成分
    • enzalutamide 40.0 mg
剂型Film-coated tablet
上市许可持有人Sandoz B.V. Veluwezoom 22 1327 AH Almere The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Enzalutamide Sandoz 40 mg, filmomhulde tabletten
互认成员国 - 产品名称
    • Latvia (LV)
    • Greece (GR)
    • Malta (MT)
      Enzalutamide Sandoz 40 mg film coated tablets
    • Sweden (SE)
    • Norway (NO)
    • Bulgaria (BG)
      Enzalutamide Sandoz 40 mg film-coated tablets
    • Poland (PL)
      Enzalutamid Sandoz
    • Germany (DE)
      Enzalutamid HEXAL 40 mg Filmtabletten
    • Cyprus (CY)
      Enzalutamide Sandoz 40 mg film-coated tablets
    • Slovenia (SI)
    • Romania (RO)
      Enzalutamidă Sandoz 40 mg,comprimate filmate
    • Denmark (DK)
    • Czechia (CZ)
      Enzalutamide Sandoz
    • Slovakia (SK)
    • Iceland (IS)
    • Estonia (EE)
    • Ireland (IE)
    • Finland (FI)
    • Austria (AT)
    • Croatia (HR)
    • France (FR)
    • Hungary (HU)
    • Spain (ES)
    • Lithuania (LT)
      Enzalutamide Sandoz 40 mg plėvele dengtos tabletės
    • Italy (IT)
许可日期2022/12/01
最近更新日期2025/09/16
药物ATC编码
    • L02BB04 enzalutamide
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase